Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Stock Information for Intensity Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Intensity Therapeutics Inc.

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results
Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
Accuray to Participate in the Jefferies Global Healthcare Conference 2025
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System
Accuray Reports Fiscal 2025 Third Quarter Financial Results
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.